Ae-June Wang
12Patents
4h-index
18Co-inventors
53Inventor score
Filing activity: Aug 24, 2001 → Nov 2, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6538030B2 | Treating radiation fibrosis | Human Necessities | 16 | Expired |
| US7446096B2 | Glutathione based delivery system | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8067380B2 | Glutathione-based delivery system | Emerging Cross-Sectional Technologies | 6 | Active |
| US8569239B2 | Glutathione based delivery system | Emerging Cross-Sectional Technologies | 5 | Active |
| US7704956B2 | Glutathione-based delivery system | Emerging Cross-Sectional Technologies | 3 | Active |
| US7588778B2 | Delivery carrier for targeting to cells expressed with somatostatin receptors | Human Necessities | 3 | Expired |
| US7700564B2 | Glutathione based delivery system | Emerging Cross-Sectional Technologies | 2 | Active |
| US7820204B2 | Drug delivery system targeting to estrogen receptor over-expressed cells | Emerging Cross-Sectional Technologies | 1 | Active |
| US7803398B2 | Targeted delivery system | Human Necessities | 0 | Active |
| US8673863B2 | Glutathione-based delivery system | Emerging Cross-Sectional Technologies | 0 | Active |
| US7485320B2 | Liposome for incorporating large amounts of hydrophobic substances | Human Necessities | 0 | Expired |
| US8128945B2 | Drug delivery system targeting to estrogen receptor over-expressed cells | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.